Cervical Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Cervical Cancer, including details on symptoms, vaccine, screening, treatment, human papilloma virus (hpv), information.

Volume 5 (2008), Issue 9 (September)

1. Frozen-section evaluation of cervical adenocarcinoma at time of radical trachelectomy: pathologic pitfalls and the application of an objective scoring system.
   Gynecol Oncol, 110(3): 316-23. [Abstract] [Full-text]
2. Clinical efficacy of modified preoperative neoadjuvant chemotherapy in the treatment of locally advanced (stage IB2 to IIB) cervical cancer: randomized study.
   Gynecol Oncol, 110(3): 308-15. [Abstract] [Full-text]
3. MVP expression is related to IGF1-R in cervical carcinoma patients treated by radiochemotherapy.
   Gynecol Oncol, 110(3): 304-7. [Abstract] [Full-text]
4. Up-regulation of VEGF, c-fms and COX-2 expression correlates with severity of cervical cancer precursor (CIN) lesions and invasive disease.
   Gynecol Oncol, 110(3): 445-51. [Abstract] [Full-text]
5. Management of cryotherapy-ineligible women in a "screen-and-treat" cervical cancer prevention program targeting HIV-infected women in Zambia: lessons from the field.
   Gynecol Oncol, 110(3): 402-7. [Abstract] [Full-text]
6. Indications for adjuvant radiotherapy treatment after surgery and novel modalities for treatment.
   Gynecol Oncol, 110(3): S41-4. [Abstract] [Full-text]
7. Natural history and epidemiology of HPV infection and cervical cancer.
   Gynecol Oncol, 110(3): S4-7. [Abstract] [Full-text]
8. The role of Notch signaling in human cervical cancer: implications for solid tumors.
   Oncogene, 27(38): 5110-4. [Abstract] [Full-text]
9. Novel chemotherapy approaches in chemoradiation protocols.
   Gynecol Oncol, 110(3): S45-8. [Abstract] [Full-text]
10. Current imaging modalities in the diagnosis of cervical cancer.
    Gynecol Oncol, 110(3): S49-54. [Abstract] [Full-text]
11. Role of PET/CT in the evaluation of cervical cancer.
    Gynecol Oncol, 110(3): S55-9. [Abstract] [Full-text]
12. Surgical treatment of recurrent cervical cancer: state of the art and new achievements.
    Gynecol Oncol, 110(3): S60-6. [Abstract] [Full-text]
13. Clinical role of cervical cancer vaccination: when and whom to vaccinate?
    Gynecol Oncol, 110(3): S15-6. [Abstract] [Full-text]
14. Current techniques in screening for cervical cancer in Spain: updated recommendations.
    Gynecol Oncol, 110(3): S8-S10. [Abstract] [Full-text]
15. Cervical cancer vaccination indications, efficacy, and side effects.
    Gynecol Oncol, 110(3): S11-4. [Abstract] [Full-text]
16. The current role of neoadjuvant chemotherapy in the management of cervical carcinoma.
    Gynecol Oncol, 110(3): S36-40. [Abstract] [Full-text]
17. Vaginal approaches to fertility-sparing surgery in invasive cervical cancer.
    Gynecol Oncol, 110(3): S29-32. [Abstract] [Full-text]
18. The Gynecologic Oncology Group's role in the treatment of recurrent cervix cancer: current clinical trials.
    Gynecol Oncol, 110(3): S77-80. [Abstract] [Full-text]
19. Update on novel therapeutic agents for cervical cancer.
    Gynecol Oncol, 110(3): S72-6. [Abstract] [Full-text]
20. Impact of extraperitoneal lymphadenectomy on treatment and survival in patients with locally advanced cervical cancer.
    Gynecol Oncol, 110(3): S33-5. [Abstract] [Full-text]
21. Chemotherapy for recurrent and metastatic cervical cancer.
    Gynecol Oncol, 110(3): S67-71. [Abstract] [Full-text]
22. Lymphatic mapping and sentinel lymph node detection in women with cervical cancer.
    Gynecol Oncol, 110(3): S17-20. [Abstract] [Full-text]
23. Fertility preservation in patients with early cervical cancer: radical trachelectomy.
    Gynecol Oncol, 110(3): S25-8. [Abstract] [Full-text]
24. Laparoscopic and robotic techniques for radical hysterectomy in patients with early-stage cervical cancer.
    Gynecol Oncol, 110(3): S21-4. [Abstract] [Full-text]
25. Molecular diagnosis of sentinel lymph node metastases in cervical cancer using squamous cell carcinoma antigen.
    Clin Cancer Res, 14(17): 5571-8. [Abstract] [Full-text]
26. Conservatively treated glassy cell carcinoma of the cervix.
    World J Surg Oncol, 6: 92. [Abstract] [Full-text]
27. Clinical impact of preoperative screening for gastric mucin secretion in cervical discharge by HIK1083-labeled latex agglutination test.
    Am J Clin Pathol, 130(4): 585-94. [Abstract] [Full-text]
28. Targeting pro-apoptotic trail receptors sensitizes HeLa cervical cancer cells to irradiation-induced apoptosis.
    Int J Radiat Oncol Biol Phys, 72(2): 543-52. [Abstract] [Full-text]
29. Distribution of HPV genotypes in uterine cervical lesions in Yanbian, northern China.
    Pathol Int, 58(10): 643-7. [Abstract] [Full-text]
30. Pelvic bone complications after radiation therapy of uterine cervical cancer: evaluation with MRI.
    AJR Am J Roentgenol, 191(4): 987-94. [Abstract] [Full-text]
31. Activating NK cell receptor ligands are differentially expressed during progression to cervical cancer.
    Int J Cancer, 123(10): 2343-53. [Abstract] [Full-text]
32. Trade-offs in cervical cancer prevention: balancing benefits and risks.
    Arch Intern Med, 168(17): 1881-9. [Abstract] [Full-text]
33. Potential barriers to HPV vaccine provision among medical practices in an area with high rates of cervical cancer.
    J Adolesc Health, 43(4): S61-7. [Abstract] [Full-text]
34. Age-specific prevalence of infection with human papillomavirus in females: a global review.
    J Adolesc Health, 43(4): S5-25, S25.e1-41. [Abstract] [Full-text]
35. Updated guidelines for papanicolaou tests, colposcopy, and human papillomavirus testing in adolescents.
    J Adolesc Health, 43(4): S41-51. [Abstract] [Full-text]
36. HPV Vaccines: today and in the Future.
    J Adolesc Health, 43(4): S26-40. [Abstract] [Full-text]
37. Human papillomavirus infection and the primary and secondary prevention of cervical cancer.
    Cancer, 113(7): 1980-93. [Abstract] [Full-text]
38. Clinical implications of elevated pretreatment carcinoembryonic antigen in patients with advanced squamous cell carcinoma of the uterine cervix.
    Tumour Biol, 29(4): 255-61. [Abstract] [Full-text]
39. A pilot study on the distribution of human papillomavirus genotypes and HPV-16 variants in cervical neoplastic lesions from Ecuadorian women.
    J Med Virol, 80(11): 1959-65. [Abstract] [Full-text]

© 2004-2010 Cervical Cancer Research Today. All Rights Reserved.